A bill to lower the price of insulin drugs and supplies for more North Dakotans attracted passionate discussion at a Thursday ...

House Bill 1114 would set out-of-pocket costs for a monthly supply of insulin at $25 for the North Dakota commercial ...

If adopted as currently written, House Bill 1114 would set out-of-pocket costs for a monthly supply of insulin at $25 for the North Dakota commercial insurance market. Under state law, however, North ...

Israel-headquartered Oramed Pharmaceutical is developing its own oral insulin ORMD-0801, and presented data from a phase 2b trial in San Diego. Other companies are looking to administer insulin ...

A study comparing oral glucose-lowering agents to insulin for gestational diabetes found no non-inferiority in preventing ...

Beta Bionics is commercializing innovative insulin delivery technologies, but faces challenges in achieving profitability.

Lawmakers in North Dakota will hear testimony on a bill that would lower the price of insulin drugs and supplies on Thursday.

Insulin has long been the typical pharmacological go-to agent for gestational diabetes, the researchers pointed out, but oral ...

New research about to get underway at the University of Virginia could help make life easier for people with Type One Diabetes- by possibly developing a fully automated insulin pump.